GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Donna Conroy ...
Bioanalytical method development and validation are at the forefront of ensuring rigorous, reproducible and reliable data in both drug development and clinical diagnostics. The field encompasses the ...
Southwest Research Institute has upgraded its nuclear magnetic resonance (NMR) laboratory to offer robust chemical analysis of organic compounds used in drug discovery and development.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results